Sneez, LLC Selected as a Venture Atlanta 2020 Showcase Company


Image of simple survey that screens for what the CDC recognizes as symptoms of COVID-19

Access to real-time health screening and tracking information is more important now than ever, and Sneez delivers.

Sneez, LLC announced today that it has been chosen out of a record-breaking 400 applicants as one of the top technology companies in the Southeast to present at Venture Atlanta 2020. Now in its 14th year, the annual conference to be held October 21-22, pivoted to a fully virtual format, Venture Atlanta Live Online. One of the nation’s best venture capital conferences continues to showcase innovators from the hottest tech markets in the US and boosts its largest number of selected companies and represented investor funds to date. Even in light of COVID-19, Venture Atlanta continues to fuel capital and growth, serving the needs of the region’s vibrant tech community.

“We are honored to have been selected as a Showcase Company of Venture Atlanta 2020,” said Sneez, LLC CEO, Danielle Lamphier. “Our portfolio of health and wellness technology solutions is rapidly gaining traction, and this opportunity to network with other growth minded innovators and investors couldn’t be more timely. Access to real-time health screening and tracking information is more important now than ever, and Sneez delivers.”

Sneez, LLC, is the creator of the leading mobile application for real-time illness tracking, the Sneez app. The company recently added SneezSafe to its portfolio of wellness technology solutions. This new web-based tool is designed for employers and other organizations, such as colleges and universities, to enable employees to screen for symptoms associated with COVID-19 each day before going to work or class. The customizable tool uses the latest CDC guidelines and decision logic to process user data instantly, directing users to seek further evaluation or connect to care when needed – right from the platform. SneezSafe features a robust employer reporting dashboard and is approved by the Institutional Review Board (IRB) to serve as a data gathering tool for the Community Research Partnership National COVID-19 Study conducted through Wake Forest University School of Medicine.

“Venture Atlanta has become the authority for recognizing technology innovation across the Southeast and beyond, connecting the best and brightest innovators with top-tier, national investors and other leaders in our technology ecosystem that helps drive success and results with over $4.5 billion in funding awarded to date,” said Venture Atlanta CEO Allyson Eman. “This year, we’ve pivoted to a digital format to best serve the needs of our vibrant tech community and are thrilled to be showcasing our largest line up of companies ever. These companies reflect our incredible pool of talented people, inspiring innovation, and continued opportunities for growth within the technology community.”

Venture Atlanta Live Online will offer an unparalleled experience that streams two days of immersive events and interactive networking opportunities. Attendees will be able to connect with others at the conference, set up one-on-one meetings, stroll the virtual show floor, watch pitches in real-time, and use features like live chat, and audience polling. Atlanta-based independent investment management firm, Invesco, is this year’s premier sponsor, with Cherry Bekaert, Nelson Mullins and Truist as additional headline sponsors. Venture Atlanta Live Online will conclude with TechSquare Labs’ Atlanta Startup Battle, in which top five companies will pitch on stage against one another to win a $100,000 investment.

To learn more about the Sneez, LLC, portfolio of products, visit http://www.sneezapp.com and http://www.sneezsafe.com. For additional information about Venture Atlanta, to register for the event or to view the conference schedule, please visit http://www.ventureatlanta.org.

About Venture Atlanta

Venture Atlanta, the Southeast’s technology innovation event, is where the region’s most promising tech companies meet the country’s top-tier investors. This year’s event is going all digital through Venture Atlanta Live Online.

As the Southeast’s largest investor showcase helping launch more than 400 companies and raise over $4.5 billion in funding to date, the event connects the region’s top entrepreneurs with local and national investors and others in the technology ecosystem who can help them raise the capital they need to grow their businesses. The annual non-profit event is a collaboration of the Atlanta CEO Council, Metro Atlanta Chamber and the Technology Association of Georgia (TAG). For more information, visit http://www.ventureatlanta.org. For updates, follow us on Twitter and visit our blog.

About Sneez, LLC

Sneez, LLC, uses technology and health data integration to help local communities stay informed and healthy. The Sneez brand was born when pediatric doctors, William Satterwhite, MD and Steven Hodges, MD, created the Sneez app in 2016 – the first of its kind real-time illness tracking app. The Sneez app uses diagnosis data from local physicians and urgent care locations to inform the public of a variety of sicknesses occurring in their specific geography, including flu, colds, strep throat and other common illnesses. This data is used to create a virtual heat map of illnesses circulating in local communities by zip code. The app also helps consumers and their families connect with local healthcare providers through scheduling in-office and virtual visits with providers, as well as equipping users with helpful information such as the wait times at their local emergency room.

In response to COVID-19, Sneez has launched SneezSafe, a workplace solution for health screening and care. The web-based platform screens employees and other community members for COVID-19 through a simple daily survey and connects them with healthcare providers for evaluation and treatment. For more information, please visit http://www.sneezapp.com and http://www.SneezSafe.com. For updates, follow us on LinkedIn.

# # #

Share article on social media or email:

Leave a Reply